Many potential clinical sites in Africa need to develop additional capacity before they can take part in Stringent Regulatory Authority (SRA) - quality clinical trials. By entering the Clinical Trials Community Africa Network (CTCAN), sites and laboratories will be able to access a clinical trial preparedness framework. Through the proposed capability development activities, sites and laboratories will be strengthened to generate SRA-quality data, which in turn will be informative for new policies and practices, and lead to earlier access to new treatments.

While governmental and non-governmental organisations (NGOs), pharmaceutical companies, and other public-private sector actors have established important capacity development programmes in Africa, CTCAN draws the different programmes and data together in, or linked to, a single platform.

​

Alignment between these Africa-led programmes and clinical research programmes of clinical trials sponsors will ultimately create a greater, sustainable, and cost-effective impact.